The ionotropic glutamate receptor GRIN2A and the metabotropic glutamate receptor GRM3 were found to be mutated in 25% and 16%, respectively, of melanoma samples, but without recurrent mutations for GRIN2A and with only a small percentage of recurrent GRM3 mutations. The gene discussed is GRM3; the disease is melanoma.